Literature DB >> 2767896

Pneumococcal serum antibody concentrations during the first three years of life: a study of otitis-prone and non-otitis-prone children.

K Prellner1, O Kalm, G Harsten, J Heldrup, V A Oxelius.   

Abstract

One hundred and thirteen children were followed prospectively from birth until the age of 3, serum being obtained from cord blood, and at the ages of 3, 6, 12, 18, 24, 30 and 36 months. Thirteen children developed recurrent acute otitis media (rAOM), 29 remained very healthy and the remaining children formed an intermediate group. Cord serum concentrations were determined of total IgG class, of IgG1 and IgG2 subclasses, as well as of specific IgG antibodies against the pneumococcal capsular types, 3, 6A and 19F. The specific pneumococcal IgG as well as IgA and IgM antibodies were also followed in the sequential serum samples up to the age of 3 in the rAOM and healthy children. Despite total IgG class and IgG1 and IgG2 subclass concentrations being of the same magnitude in cord serum of rAOM (median: 11.15, 7.48 and 2.16 g/l for IgG, IgG1 and IgG2, respectively) as in that of healthy children (median: 10.21, 8.16 and 2.16 g/l, respectively), both in cord serum and in most serum samples drawn during the first year of life, specific IgG antibodies against types 6A and 19F, but not against type 3, were significantly lower in the rAOM group than in the healthy children. In the intermediate group, cord serum concentrations of specific IgG antibodies to type 6A were of the same magnitude as in the healthy children. The only significant difference in specific IgM and IgA antibody concentrations against types 3, 6A and 19F between the two groups was noted for type 6A antibodies at 36 months of age where rAOM children exhibited lower values. The results indicate an association between pre-existing low specific IgG antibody levels against AOM-associated pneumococcal types and the development of rAOM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767896     DOI: 10.1016/0165-5876(89)90052-9

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

Review 1.  New concepts in the pathophysiology and management of middle ear disease in childhood.

Authors:  S I Pelton
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  Cytokines in nasopharyngeal secretions; evidence for defective IL-1 beta production in children with recurrent episodes of acute otitis media.

Authors:  K Lindberg; B Rynnel-Dagöö; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

Review 3.  Otitis media as a presenting complaint in childhood immunodeficiency diseases.

Authors:  Nevin W Wilson; Mary Beth Hogan
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

4.  Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides.

Authors:  Lea-Ann S Kirkham; Selma P Wiertsema; Karli J Corscadden; Tulia Mateus; Gemma L Mullaney; Guicheng Zhang; Peter C Richmond; Ruth B Thornton
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

Review 5.  Natural history, definitions, risk factors and burden of otitis media.

Authors:  Kelvin Kong; Harvey L C Coates
Journal:  Med J Aust       Date:  2009-11-02       Impact factor: 7.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.